{"id":"tp-44782","type":"article-newspaper","title":"Acumen Shares Fall More Than 80% After Alzheimer’s Trial Miss","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/44782","datePublished":"2026-10-30T14:31:49.000Z","dateModified":"2026-10-30T14:31:49.000Z","language":"en","abstract":"The midstage ALTITUDE-AD study tested sabirnetug. Acumen had $78.6 million in cash, cash equivalents and marketable securities as of Sept. 30.","section":"Business","references":[{"title":"third-quarter results","url":"https://www.tokenpost.com/news/business/40999"}]}